Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: C. R. BardUpdated: Aug 10, 2026Locations: 17
Eligibility criteria

Subject must be either male or non-pregnant female ≥ 18 years of age with an exp... [+7]

The subject is in a hypercoagulable state. [+14]

Status: Not yet recruiting

Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICU

The goal of this observational pilot study is to learn about the ability of the PureWick® Flex Female External Catheter and the PureWIck® Male External Catheter to capture urine output in adult ICU patients compared to indwelling urinary catheters. The study will also gather feedback from ICU clinicians about the suitability of PureWick® urine output data to inform clinical decision-making.

Participants needed: 32
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: C. R. BardUpdated: Aug 4, 2026Locations: 1
Eligibility criteria

Adult patients =18 years at the time of ICU admission [+2]

Frequent episodes of bowel incontinence without a fecal management system in pla... [+5]

Status: Recruiting

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Prospective, randomized, controlled study to assess the safety and effectiveness of GalaFLEX LITE™ Scaffold in revision surgery for reduction of capsular contracture recurrence and/or malposition in implant-based breast augmentation patients versus patients undergoing conventional revision surgery with no supportive matrix or acellular dermal matrix (ADM). Subjects will be randomized 2:1 to receive either GalaFLEX LITE™ Scaffold or standard care (no ADM or matrix placement). This study is designed using an adaptive approach. The number of the treated breasts will range between 250 and 530.

Participants needed: 250
Trial details
Age: 22-70Biological sex: FemaleType: InterventionalSponsor: C. R. BardUpdated: May 22, 2026Locations: 34
Eligibility criteria

Genetically female ≥22 and ≤70 years of age; [+8]

BMI <18 or >35 [+35]

Status: Not yet recruiting

Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection

Post-market, observational study to assess effectiveness of TissuePatch SF in managing/preventing air leaks after lung resection.

Participants needed: 250
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: C. R. BardUpdated: Feb 10, 2026
Eligibility criteria

Is ≥18 and <80 years of age [+3]

Women who are pregnant or lactating or, if of childbearing potential, are unwill... [+9]

Status: Recruiting

Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension

This Study is a prospective, multi-center, single-arm objective perform an criteria (OPC) study. A 12 months follow-up study on the patients who intend to receive the treatment of cirrhosis and complications of portal hypertension with the TIPS Stent Graft will be conducted. The primary evaluation endpoint of this Study is the stent patency at 6 months after treatment completion .

Participants needed: 166
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: C. R. BardUpdated: Dec 19, 2025Locations: 1
Eligibility criteria

The subject who is 18 years old or above but 75 years old or below; [+4]

The subject who is pregnant or lactating or plan to get pregnant during the clin... [+24]

Status: Recruiting

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.

Participants needed: 600
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: C. R. BardUpdated: Dec 17, 2025Locations: 2
Eligibility criteria

Subject or legally authorized representative provides written informed consent u... [+5]

Subject is unable or unwilling to comply with follow-up procedures and visits. [+5]